DE3049179A1
(de)
*
|
1975-03-20 |
1982-07-29 |
Röhm GmbH, 6100 Darmstadt |
Bindemittel fuer arzneimittelueberzuege.
|
JPS5855125B2
(ja)
*
|
1980-03-10 |
1983-12-08 |
信越化学工業株式会社 |
固形薬剤用腸溶性コ−テイング剤組成物
|
EP0052075A1
(de)
*
|
1980-11-12 |
1982-05-19 |
Ciba-Geigy Ag |
Körnige Arzneimittel-Retardform
|
US4456628A
(en)
*
|
1981-01-07 |
1984-06-26 |
Bauer Kurt H |
Process for film-coating a particulate solid, and emulsions for conducting the process
|
US4340582A
(en)
*
|
1981-01-15 |
1982-07-20 |
Abbott Laboratories |
Erythromycin base tablets
|
US4377568A
(en)
*
|
1981-08-12 |
1983-03-22 |
Merck Sharp & Dohme (I.A.) Corp. |
Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
|
JPS5877825A
(ja)
*
|
1981-11-05 |
1983-05-11 |
Eisai Co Ltd |
腸溶性固形製剤
|
JPS5973529A
(ja)
*
|
1982-10-12 |
1984-04-25 |
Sankyo Co Ltd |
被覆固形製剤の製造法
|
US4518433A
(en)
*
|
1982-11-08 |
1985-05-21 |
Fmc Corporation |
Enteric coating for pharmaceutical dosage forms
|
US4462839A
(en)
*
|
1983-06-16 |
1984-07-31 |
Fmc Corporation |
Enteric coating for pharmaceutical dosage forms
|
JPS6051124A
(ja)
*
|
1983-08-31 |
1985-03-22 |
Kohjin Co Ltd |
腸溶性材コ−ティング液
|
CH658188A5
(de)
*
|
1984-03-23 |
1986-10-31 |
Ciba Geigy Ag |
Lagerstabile schnellzerfallende pharmazeutische presslinge.
|
GB8414220D0
(en)
*
|
1984-06-04 |
1984-07-11 |
Sterwin Ag |
Medicaments in unit dose form
|
US4600645A
(en)
*
|
1985-01-31 |
1986-07-15 |
Warner-Lambert Company |
Process for treating dosage forms
|
US4816259A
(en)
*
|
1987-02-12 |
1989-03-28 |
Chase Chemical Company, L.P. |
Process for coating gelatin capsules
|
US4795641A
(en)
*
|
1987-08-20 |
1989-01-03 |
Eastman Kodak Company |
Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
|
US4816298A
(en)
*
|
1987-11-27 |
1989-03-28 |
The Dow Chemical Company |
Method of making a granular, cold water dispersible coating composition
|
US4960814A
(en)
*
|
1988-06-13 |
1990-10-02 |
Eastman Kodak Company |
Water-dispersible polymeric compositions
|
US5025004A
(en)
*
|
1988-06-13 |
1991-06-18 |
Eastman Kodak Company |
Water-dispersible polymeric compositions
|
US5194464A
(en)
*
|
1988-09-27 |
1993-03-16 |
Takeda Chemical Industries, Ltd. |
Enteric film and preparatoin thereof
|
GB8913889D0
(en)
*
|
1989-06-16 |
1989-08-02 |
May & Baker Ltd |
New compositions of matter
|
US5248516A
(en)
*
|
1989-12-19 |
1993-09-28 |
Fmc Corporation |
Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
|
JP3142919B2
(ja)
*
|
1991-11-06 |
2001-03-07 |
旭化成株式会社 |
セルロース誘導体ラテックス及びその製法
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
AU7219094A
(en)
*
|
1993-07-14 |
1995-02-13 |
Opta Food Ingredients, Inc. |
Shellac dispersions and coatings, and method of making
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
GB2285989A
(en)
*
|
1994-01-28 |
1995-08-02 |
Merck Frosst Canada Inc |
Aqueous formulations for enteric coatings
|
JP3492787B2
(ja)
*
|
1994-04-15 |
2004-02-03 |
信越化学工業株式会社 |
固形製剤のコーティング用水性エマルジョンの濃縮方法
|
PT1078628E
(pt)
*
|
1994-07-08 |
2009-01-27 |
Astrazeneca Ab |
Forma de dosagem em comprimidos com unidades múltiplas
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
US5686106A
(en)
*
|
1995-05-17 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form for colonic delivery
|
SE9600071D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients I
|
SE9600072D0
(sv)
*
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients II
|
SE512835C2
(sv)
*
|
1996-01-08 |
2000-05-22 |
Astrazeneca Ab |
Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
FI105566B
(fi)
*
|
1996-12-31 |
2000-09-15 |
Valtion Teknillinen |
Menetelmä polymeeridispersioiden valmistamiseksi
|
US6780903B2
(en)
|
1996-12-31 |
2004-08-24 |
Valtion Teknillinen Tutkimuskeskus |
Process for the preparation of polymer dispersions
|
EP1745774A3
(en)
|
1997-08-11 |
2007-04-11 |
Pfizer Products Inc. |
Solid pharmaceutical dispersions with enhanced bioavailability
|
US5985313A
(en)
*
|
1997-10-22 |
1999-11-16 |
New York Blood Center, Inc. |
Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
|
US6165493A
(en)
*
|
1997-10-22 |
2000-12-26 |
New York Blood Center, Inc. |
"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
|
US6559158B1
(en)
|
1997-11-03 |
2003-05-06 |
Ur Labs, Inc. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
|
US6274591B1
(en)
|
1997-11-03 |
2001-08-14 |
Joseph F. Foss |
Use of methylnaltrexone and related compounds
|
US20030158220A1
(en)
*
|
1997-11-03 |
2003-08-21 |
Foss Joseph F. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
|
JP2000095709A
(ja)
|
1998-09-25 |
2000-04-04 |
Shin Etsu Chem Co Ltd |
水系コーティング剤及び固形医薬製剤の製造方法
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
ES2306646T3
(es)
|
1999-02-09 |
2008-11-16 |
Pfizer Products Inc. |
Composiciones de farmacos basicos con biodisponibilidad incrementada.
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US7138143B1
(en)
|
1999-09-30 |
2006-11-21 |
Otsuka Pharmaceutical Company, Limited |
Coated preparation soluble in the lower digestive tract
|
ES2374717T3
(es)
|
1999-10-29 |
2012-02-21 |
Euro-Celtique S.A. |
Formulaciones de hidrocodona de liberación controlada.
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US7223421B2
(en)
*
|
2000-06-30 |
2007-05-29 |
Mcneil-Ppc, Inc. |
Teste masked pharmaceutical particles
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
IT1319655B1
(it)
|
2000-11-15 |
2003-10-23 |
Eurand Int |
Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
|
US20020119196A1
(en)
*
|
2000-12-21 |
2002-08-29 |
Narendra Parikh |
Texture masked particles containing an active ingredient
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
ATE446751T1
(de)
*
|
2001-06-05 |
2009-11-15 |
Univ Chicago |
Verwendung von methylnaltrexon zur behandlung von immunsuppression
|
CN104383542B
(zh)
|
2003-04-08 |
2017-09-26 |
普罗热尼奇制药公司 |
包含甲基纳曲酮的药物配方
|
US20040259899A1
(en)
*
|
2003-04-08 |
2004-12-23 |
Sanghvi Suketu P. |
Combination therapy for constipation
|
MXPA05010819A
(es)
*
|
2003-04-08 |
2006-03-30 |
Progenics Pharm Inc |
Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
|
US7115283B2
(en)
*
|
2003-05-06 |
2006-10-03 |
Access Business Group International Llc |
Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals
|
BRPI0509148B8
(pt)
|
2004-03-22 |
2021-05-25 |
Abbott Products Gmbh |
composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina contendo tensoativos, seus usos e respectivos processos de fabricação
|
US8207232B2
(en)
*
|
2004-05-28 |
2012-06-26 |
Bend Research, Inc. |
Pharmaceutical compositions with enhanced performance
|
JP2008528497A
(ja)
*
|
2005-01-20 |
2008-07-31 |
プロジェニックス ファーマシューティカルズ,インコーポレーテッド |
メチルナルトレキソンおよび関連化合物の術後性胃腸障害のための使用
|
MX2007010833A
(es)
*
|
2005-03-07 |
2009-02-17 |
Univ Chicago |
Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
|
US8524731B2
(en)
*
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
US9662325B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
AR057325A1
(es)
*
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
US20080194611A1
(en)
*
|
2005-06-03 |
2008-08-14 |
Alverdy John C |
Modulation of Cell Barrier Dysfunction
|
JP5140586B2
(ja)
|
2005-07-29 |
2013-02-06 |
アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
滅菌パンクレアチン粉末の製法
|
US11266607B2
(en)
|
2005-08-15 |
2022-03-08 |
AbbVie Pharmaceuticals GmbH |
Process for the manufacture and use of pancreatin micropellet cores
|
US9198871B2
(en)
|
2005-08-15 |
2015-12-01 |
Abbott Products Gmbh |
Delayed release pancreatin compositions
|
US10072256B2
(en)
|
2006-05-22 |
2018-09-11 |
Abbott Products Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
AU2007275033A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophobic abuse deterrent delivery system
|
TW200817048A
(en)
*
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
PT2079445E
(pt)
|
2007-02-20 |
2016-02-29 |
Allergan Pharmaceuticals Internat Ltd |
Composições de enzimas digestivas estáveis
|
SI2139890T1
(sl)
*
|
2007-03-29 |
2014-12-31 |
Wyeth Llc |
Antagonisti perifernih opioidnih receptorjev in njih uporaba
|
PA8774201A1
(es)
|
2007-03-29 |
2009-06-23 |
Progenics Pharm Inc |
Antagonista del receptor
|
MX351611B
(es)
|
2007-03-29 |
2017-10-20 |
Wyeth Llc |
Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
|
EP2730578A1
(en)
|
2008-02-06 |
2014-05-14 |
Progenics Pharmaceuticals, Inc. |
Preparation and use of (r),(r)-2,2'-bis-methylnal trexone
|
WO2009109856A2
(en)
|
2008-03-07 |
2009-09-11 |
Axcan Pharma Inc. |
Method for detecting infectious parvovirus in pharmaceutical preparations
|
EP2278966B1
(en)
*
|
2008-03-21 |
2019-10-09 |
The University of Chicago |
Treatment with opioid antagonists and mtor inhibitors
|
CA2676881C
(en)
|
2008-09-30 |
2017-04-25 |
Wyeth |
Peripheral opioid receptor antagonists and uses thereof
|
RU2563133C2
(ru)
*
|
2009-08-28 |
2015-09-20 |
Геркулес Инкорпорейтед |
Пленкообразующая композиция для нанесения покрытий на основе твердых порошкообразных соединений
|
MX348118B
(es)
|
2010-10-01 |
2017-05-26 |
Aptalis Pharma Ltd |
Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia.
|
DK2741766T3
(en)
|
2011-08-08 |
2016-01-11 |
Aptalis Pharma Ltd |
Process for dissolving solid compositions containing digestive enzymes
|
US9492550B2
(en)
|
2013-03-01 |
2016-11-15 |
Hercules Llc |
Pharmaceutical compositions with enhanced performance and improved processability
|
EP3030257B1
(en)
|
2013-08-09 |
2020-02-19 |
Allergan Pharmaceuticals International Limited |
Digestive enzyme composition suitable for enteral administration
|
EP2837391B1
(en)
*
|
2013-08-12 |
2017-05-10 |
Shin-Etsu Chemical Co., Ltd. |
Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate
|
AU2015275860A1
(en)
|
2014-06-19 |
2016-11-03 |
Aptalis Pharma Ltd. |
Methods for removing viral contaminants from pancreatic extracts
|
EP3206491B1
(en)
|
2014-10-17 |
2019-11-27 |
Salix Pharmaceuticals, Inc. |
Use of methylnaltrexone to attenuate tumor progression
|
US20160331689A1
(en)
|
2015-05-12 |
2016-11-17 |
SE Tylose USA, Inc. |
Aqueous enteric coating composition
|
CN105330754A
(zh)
*
|
2015-11-25 |
2016-02-17 |
泰安瑞泰纤维素有限公司 |
新型绿色反应介质下羟丙基甲基纤维素衍生物的制备方法
|